Compare ERIE & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ERIE | RVTY |
|---|---|---|
| Founded | 1925 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.5B | 11.8B |
| IPO Year | 2011 | 1994 |
| Metric | ERIE | RVTY |
|---|---|---|
| Price | $247.04 | $85.65 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 15 |
| Target Price | N/A | ★ $113.00 |
| AVG Volume (30 Days) | 197.0K | ★ 1.1M |
| Earning Date | 01-01-0001 | 04-27-2026 |
| Dividend Yield | ★ 2.41% | 0.33% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 491.00 | 2.07 |
| Revenue | $1,691,774,000.00 | ★ $3,311,822,000.00 |
| Revenue This Year | $6.83 | $6.34 |
| Revenue Next Year | N/A | $5.10 |
| P/E Ratio | ★ $0.49 | $40.84 |
| Revenue Growth | ★ 5.96 | N/A |
| 52 Week Low | $237.59 | $81.36 |
| 52 Week High | $434.00 | $118.30 |
| Indicator | ERIE | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 34.11 | 29.71 |
| Support Level | N/A | $82.98 |
| Resistance Level | $290.84 | $94.75 |
| Average True Range (ATR) | 9.30 | 3.09 |
| MACD | -2.41 | -0.99 |
| Stochastic Oscillator | 22.68 | 13.74 |
Erie Indemnity Co mainly performs services on behalf of the Erie Insurance Exchange relating to sales, underwriting, and issuance of policies. Erie Indemnity's results are tied to the performance of the Insurance Exchange, which principally provides automobile and homeowners insurance for individuals, along with multiperil, workers' compensation, and commercial automobile insurance for its commercial clients. The company operates exclusively in the United States.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.